View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Andres Bolumburu
  • Andres Bolumburu

CELLNEX: FY2025 RESULTS (ANÁLISIS BANCO SABADELL)

4Q'25 vs. 4Q'24 Results Sales: € 1.058 Bn (+1.9% vs. -1.4% BS(e) and +1.0% consensus); EBITDA: € 881.0 M (+2.1% vs. +0.1% BS(e) and +1.0% consensus); FY2025 vs. FY2024 Results Sales: € 3.995 Bn (+1.4% vs. +0.5% BS(e) and +1.1% consensus); EBITDA: € 3.317 Bn (+2.1% vs. +1.5% BS(e) and +1.8% consensus); Net Profit: € -361.0 M (€ -28.0 M in FY2024);

James Ratzer
  • James Ratzer

Cellnex (Buy, €34, +8%) Q4 25: Highest organic tenancy growth for 7 y...

We think Cellnex’s organic tower demand is the highest it has been for 7 years. We see that alone as supportive for the Cellnex story.

Carole Braudeau
  • Carole Braudeau

Credit Morning 02/27/2026

INEOS Quattro: conference call comments|NIH: improvement in certain indicators in H2, but still little visibility on M&A|Ardagh Group surprises with strong increase in glass EBITDA in Q4|Clariane : Satisfactory 2025 results thanks to strong recovery in H2 25 and B2/B+ ratings assigned by Moody’s and S&P|

Carole Braudeau
  • Carole Braudeau

Morning Crédit 27/02/2026

INEOS Quattro: conference call comments|NIH : amélioration de certains indicateurs au S2 mais toujours peu de visibilité sur le M&A|Ardagh Group surprend avec une forte hausse de l’EBITDA verre au T4|Clariane : Résultats 2025 satisfaisants grâce à un bon rattrapage au 2nd semestre et ratings B2/B+ attribués par Moody’s et S&P|

Luis Arredondo
  • Luis Arredondo

GRIFOLS: RDOS. 4T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 4T'25 vs 4T'24: Ventas: 1.982 M euros (+0,4% vs +1,1% BS(e) y -1,7% consenso); EBITDA: 467,0 M euros (-11,2% vs -10,4% BS(e) y -10,8% consenso); EBIT: 271,41 M euros (-27,0% vs -8,6% BS(e) y -9,4% consenso); BDI: 98,25 M euros (+42,4% vs +65,9% BS(e) y +133,1% consenso); Rdos. 2025 vs 2024: Ventas: 7.524 M euros (+4,3% vs +4,5% BS(e) y +3,8% consenso); EBITDA: 1.825 M euros (+2,6% vs +2,8% BS(e) y +2,7% consenso); EBIT: 1.243 M euros (+4,3% vs +10,1% BS(e) y +9,8% consenso); BDI: 402,0 M e...

Luis Arredondo
  • Luis Arredondo

OHLA: RDOS. 4T’25 Y CAMBIO DE RECOMENDACIÓN A SOBREPONDERAR (ANÁLISIS ...

Rdos. 4T'25 vs 4T'24: Ventas: 884,1 M euros (-11,8% vs -4,5% BS(e)); EBITDA: 80,8 M euros (+46,4% vs +9,4% BS(e)); EBIT: 75,8 M euros (+86,7% vs -8,1% BS(e)); BDI: 47,3 M euros (+463,1% vs -77,8% BS(e)); Rdos. 2025 vs 2024: Ventas: 3.455 M euros (-5,4% vs -3,4% BS(e)); EBITDA: 194,0 M euros (+36,5% vs +22,2% BS(e)); EBIT: 128,0 M euros (+73,0% vs +21,0% BS(e)); BDI: 1,7 M euros (-49,9 M euros en 2024 vs -43,74 M euros BS(e));

Andres Bolumburu
  • Andres Bolumburu

CELLNEX: RDOS. 2025 (ANÁLISIS BANCO SABADELL)

Rdos. 4T'25 vs 4T'24: Ventas: 1.058 M euros (+1,9% vs +1,4% BS(e) y +1,0% consenso); EBITDA: 881,0 M euros (+2,1% vs +0,1% BS(e) y +1,0% consenso). Rdos. 2025 vs 2024: Ventas: 3.995 M euros (+1,4% vs +1,2% BS(e) y +1,1% consenso); EBITDA: 3.317 M euros (+2,1% vs +1,5% BS(e) y +1,8% consenso); BDI: -361,0 M euros (-28,0 M euros en 2024).

Andres Bolumburu
  • Andres Bolumburu

ACCIONA: RDOS. 2025 (ANÁLISIS BANCO SABADELL)

Rdos. 2025 vs 2024: Ventas: 20.236 M euros (+5,5% vs +3,2% BS(e) y +4,4% consenso); EBITDA: 3.211 M euros (+30,8% vs +19,0% BS(e) y +16,0% consenso); EBIT: 1.862 M euros (+41,5%); BDI: 803,0 M euros (+90,3%).

Research Department
  • Research Department

IBERIAN DAILY 27 FEBRUARY + 4Q'25 RESULTS. PREVIEWS (ANÁLISIS BANCO SA...

NEWS SUMMARY: ACCIONA, ACCIONA ENERGÍA, ACERINOX, AMADEUS, CELLNEX, COLONIAL, ELECTRICITY SECTOR, FCC, GLOBAL DOMINION, GRIFOLS, IAG, MERLIN, OHLA, REDEIA, SACYR, SOLARIA, VISCOFAN. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’25 results to be released over the coming days in Spain. Doubts continue to plague Nasdaq, but software rallies after harsh punishment European s...

Benoit Valleaux ... (+5)
  • Benoit Valleaux
  • Roland Pfaender
  • MBA
  • CFA
  • CCRA

Metrovacesa S.A.: 1 director

A director at Metrovacesa S.A. sold 20,000 shares at 13.020EUR and the significance rating of the trade was 64/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

Research Department
  • Research Department

INFORME DIARIO 27 FEBRERO + RDOS. ESPAÑA Y EUROPA. PREVIEWS (ANÁLISIS ...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACCIONA, ACCIONA ENERGÍA, ACERINOX, AMADEUS, CELLNEX, COLONIAL, FCC, GLOBAL DOMINION, GRIFOLS, IAG, MERLIN, OHLA, REDEIA, S. ELÉCTRICO, SACYR, SOLARIA, VISCOFAN. EUROPA:.n/a. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Siguen las dudas en e...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch